WO2025214463 - COMPOUND CONTAINING FUSED TRICYCLIC STRUCTURE
National phase entry is expected:
Publication Number
WO/2025/214463
Publication Date
16.10.2025
International Application No.
PCT/CN2025/088437
International Filing Date
11.04.2025
Title **
[English]
COMPOUND CONTAINING FUSED TRICYCLIC STRUCTURE
[French]
COMPOSÉ CONTENANT UNE STRUCTURE TRICYCLIQUE FUSIONNÉE
[Chinese]
含有三并环结构的化合物
Applicants **
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
Inventors
LIU, Yanlong
TANG, Xujing
YANG, Liechao
WANG, Guan
GU, Jiajia
Priority Data
202410445278.3
13.04.2024
CN
202410591345.2
13.05.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1803 | |
| EPO | Filing, Examination, Granting | 12135 | |
| Japan | Filing, Examination, Granting | 2045 | |
| South Korea | Filing, Examination, Granting | 1887 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
22,610
Contact Us
Abstract[English]
The present disclosure belongs to the field of pharmaceutical chemistry. Provided is a compound containing a fused tricyclic structure. Specifically, the present disclosure relates to a compound of formula I, or a pharmaceutically acceptable salt thereof, a preparation method therefor or a pharmaceutical composition thereof, and the use thereof in the preparation of a drug for treating or preventing tumor-related diseases.[French]
La présente divulgation relève du domaine de la chimie pharmaceutique. L'invention concerne un composé contenant une structure tricyclique fusionnée. Plus particulièrement, la présente invention concerne un composé de formule I, ou un sel pharmaceutiquement acceptable de celui-ci, son procédé de préparation ou une composition pharmaceutique de celui-ci, et son utilisation dans la préparation d'un médicament pour le traitement ou la prévention de maladies liées à une tumeur.[Chinese]
本公开属于药物化学领域，提供了一种含有三并环结构的化合物，具体而言涉及式I化合物、或其药学上可接受的盐、其制备方法或其药物组合物，及其在制备治疗或预防肿瘤相关疾病的药物中的用途。